Financials
- Market Capitalization 12.31 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-35.68
市销率
10.67
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 755 | EXEL Exelixis, Inc. - Common Stock | 54.64 USD | +0.35% | -1.07% | +3.82% | +39.96% | 13.54 B USD | ||
| 791 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 65.23 USD | +0.87% | +0.31% | +7.94% | +11.70% | 12.63 B USD | ||
| 809 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.35 USD | -0.47% | -9.23% | -0.71% | +54.49% | 12.25 B USD | ||
| 817 | HALO Halozyme Therapeutics, Inc. - Common Stock | 106.49 USD | +1.08% | -2.64% | +28.92% | +59.42% | 12.09 B USD |